ADMA | ADMA Biologics Inc
Category: Consumer goods
Quick infos Headquarters: Ramsey, New Jersey, United States Trade prices Volume: 202M Market Cap: 151.36M Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends: Next ER: November 4, 2021
Earnings History Date EPS / Forecast Revenue / Forecast August 11, 2021 -0.15 / -0.152517.83M / 16.42MBeat! May 12, 2021 -0.16 / -0.165716.05M / 14.58MBeat! March 25, 2021 -0.2 / -0.16513.96M / 12.85MBeat! November 5, 2020 -0.19 / -0.186710.28M / 9.96MBeat! August 5, 2020 -0.23 / -0.167.79M / 10.57Mview more
Historical Data Date Price Open High Low Vol Change ER Oct 8, 2021 1.1200 1.1309 1.1500
1.1100
1.38M -1.75% Oct 7, 2021 1.1400 1.1400 1.1550
1.1300
1.42M 1.79% Oct 6, 2021 1.1200 1.1200 1.1500
1.1200
718.47K -1.75% Oct 5, 2021 1.1400 1.1700 1.1700
1.1400
706.42K -0.87% Oct 4, 2021 1.1500 1.1600 1.1700
1.1500
620.07K -3.36% Oct 1, 2021 1.1900 1.1400 1.2100
1.1200
1.70M 5.31% Sep 30, 2021 1.1300 1.1500 1.1500
1.1100
1.86M 0% Sep 29, 2021 1.1300 1.2000 1.2200
1.1300
2.85M -7.38% Sep 28, 2021 1.2200 1.2300 1.2400
1.2000
1.15M -0.81% Sep 27, 2021 1.2300 1.2500 1.2700
1.2200
1.64M -1.6% view more
News
Volatile action in ADMA Biologics as Jefferies talks takeout seekingalpha.com Oct 1, 2020 12:14 am Adma Biologics up 10% on launch of COVID-19 test seekingalpha.com Sep 3, 2020 8:25 pm NIH begs to differ on FDA's EUA for convalescent plasma for COVID-19 seekingalpha.com Sep 2, 2020 3:48 am
ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions finance.yahoo.com Aug 13, 2020 5:58 pm
ADMA Biologics Reports Third Quarter 2018 Financial Results finance.yahoo.com Aug 13, 2020 5:05 pm
ADMA Biologics Reports First Quarter 2019 Financial Results finance.yahoo.com Aug 13, 2020 4:18 pm ADMA Biologics' stock rockets on heavy volume after FDA approval of immunodeficiency treatment marketwatch.com Aug 6, 2020 9:00 am FDA to fast-track COVID-19 vaccine - Financial Times seekingalpha.com Aug 31, 2020 12:57 pm Does convalescent plasma help COVID-19 patients? Studies will answer seekingalpha.com Aug 29, 2020 2:00 pm Convalescent plasma players rally on FDA emergency use nod seekingalpha.com Aug 24, 2020 6:22 pm FDA allows emergency use of convalescent plasma to treat COVID-19 seekingalpha.com Aug 24, 2020 6:39 am Convalescent plasma players under pressure on FDA hold on emergency use nod seekingalpha.com Aug 19, 2020 9:39 pm Convalescent plasma players rally on positive results from COVID-19 study seekingalpha.com Aug 14, 2020 3:45 am
ADMA Biologics Reports Business Highlights and Second Quarter 2020 Financial Results finance.yahoo.com Aug 13, 2020 4:05 pm
ADMA Biologics Rips Higher On FDA Nod For Immunodeficiency Therapy finance.yahoo.com Aug 13, 2020 10:26 am
How Many ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Did Insiders Buy, In The Last Year? finance.yahoo.com Aug 13, 2020 9:28 am
CoVIg-19 Plasma Alliance Builds Strong Momentum Through Expanded Membership and Clinical Trial Collaboration finance.yahoo.com Aug 13, 2020 8:42 am
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors finance.yahoo.com Aug 13, 2020 7:38 am
The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial finance.yahoo.com Aug 13, 2020 7:30 am
ADMA Biologics Announces Martha J. Demski Elected to Board of Directors finance.yahoo.com Aug 13, 2020 7:00 am Talk about ADMA Biologics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
